Intelligent Bio Solutions Inc. Files 8-K

Ticker: INBS · Form: 8-K · Filed: Jul 23, 2025 · CIK: 1725430

Sentiment: neutral

Topics: 8-K, regulatory-disclosure, financial-reporting

TL;DR

Intelligent Bio Solutions filed an 8-K on July 23, 2025, for regulatory and financial updates.

AI Summary

Intelligent Bio Solutions Inc. filed an 8-K on July 23, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly known as GBS Inc., is incorporated in Delaware and has its principal executive offices in New York City.

Why It Matters

This filing provides an update on the company's regulatory disclosures and financial reporting, which is important for investors to stay informed about the company's status.

Risk Assessment

Risk Level: low — This is a routine filing of an 8-K, indicating standard corporate reporting rather than a significant event.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing?

The primary purpose of this 8-K filing is to report a Regulation FD Disclosure and to provide Financial Statements and Exhibits.

When was the earliest event reported in this filing?

The earliest event reported in this filing was on July 23, 2025.

What is the current name of the registrant?

The current name of the registrant is INTELLIGENT BIO SOLUTIONS INC.

What were some of the former names of the company?

Some of the former names of the company include GBS Inc. and Glucose Biosensor Systems (Greater China) Holdings, Inc.

Where are the principal executive offices of Intelligent Bio Solutions Inc. located?

The principal executive offices of Intelligent Bio Solutions Inc. are located at 135 West 41st Street, 5th Floor, New York, NY 10036.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on July 23, 2025 regarding INTELLIGENT BIO SOLUTIONS INC. (INBS).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing